CALGARY, AB, May 17, 2026 (GLOBE NEWSWIRE) — Seegnal Inc. (TSXV:SEGN) (“Seegnal” or the “Company“) announces that the management cease trade order (the “MCTO“), issued by the Alberta Securities Commission on May 8, 2026, at the request of the Company, will no longer be in effect as of May 16, 2026.
On May 13, 2026, the Company filed its audited consolidated financial statements for the year ended December 31, 2025, together with the related management’s discussion and analysis and the Chief Executive Officer and the Chief Financial Officer certifications.
The MCTO applied only to the Chief Executive Officer and the Chief Financial Officer and did not affect the ability of the general investing public to trade in the Company’s securities.
The Company confirms that it is current with its continuous disclosure obligations and anticipates meeting its future filing requirements.
About Seegnal
Seegnal is a public company that aims to solve one of the top causes of death and injuries in the modern world – Adverse Drug Effects (ADEs). Seegnal’s Clinical Decision Support system introduces a paradigm shift in the approach to this problem by implementing a new elevated Patient-Centric Standard. Seegnal’s SaaS technology exclusively integrates at the point-of-care, unique patient-specific data like genetics, results of lab tests, ECG, smoking, allergies, food, gender, age, and the effects of many concomitant medications, while reducing the current alert load for clinicians …